No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

ASET Foot Plating System Released by TriMed

The ASET Foot Plating System is Designed to Treat Common Forefoot and Mid-Foot Indications

Editor: What To Know

  • All of the plates are low profile, and their screw holes offer the ability of a variable angle of up to 15°.
  • ASET's instrumentation allows surgeons to control compression at the fracture, fusion, or osteotomy site with the use of the patented Expander/Compression tool, dubbed by surgeons as the ‘Magic Screwdriver'.
  • This ability to apply surgeon-controlled compression (SCC) allows the surgeon to feel and apply the desired compression at the fusion site.

The ASET Foot Plating System offers unique implants to treat MTP fusions, Lapidus fusions, and TMT fusions. In addition, the system’s variety of patented Hook Plates provide additional points of fixation to bones of limited real estate without relying on thread purchase.

ASET’s instrumentation allows surgeons to control compression at the fracture, fusion, or osteotomy site with the use of the patented Expander/Compression tool, dubbed by surgeons as the ‘Magic Screwdriver’. This ability to apply surgeon-controlled compression (SCC) allows the surgeon to feel and apply the desired compression at the fusion site.

The entire array of ASET System plates are designed to accept all three sized screws (2.7, 3.5, and 4.0mm) to fit in any screw hole, reducing the need for additional inventory. All locking screws are designed to sit flush with the plate even when angled 15 degrees in either direction.

Greg Tsarukian, Senior Product Manager, emphasized that the ASET Foot Plating System is advantageous for challenging indications such as mid-foot fusions because of the unique implants, screws, and instruments. “The set’s instruments are user-friendly and intuitive, including the Magic Screwdriver tool. There is a variety of choices of locking and cortical screws that fit into all plates while using the one-size driver. All of the plates are low profile, and their screw holes offer the ability of a variable angle of up to 15°. ASET offers plenty of options in case of in-surgery revisions,” he added.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy